Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:34 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Anakinra as a Rescue Treatment for Allergic Inflammation
NCT04035109 · University of North Carolina, Chapel Hill · PHASE1/PHASE2 · withdrawn · last registry update 2022-06-08 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study stopped due to COVID-19 pandemic.” | – | Registry record, University of North Carolina, Chapel Hill |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against IL1R1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-04-14Phase 3 first posted: Swedish Orphan Biovitrum, Anakinra + Placebo (NCT05814159)
- 2023-04-10Phase 3 first posted: Istituto Giannina Gaslini, Anakinra + Prednisone (NCT05805930)
- 2023-03-14Results posted on the registry: University of Pennsylvania, Anakinra + Placebo (NCT03141983)
- 2023-03-14Results posted on the registry: University Hospital, Ghent, Anakinra + Siltuximab (NCT04330638)
- 2022-08-12Phase 3 first posted: Herlev and Gentofte Hospital, Anakinra + Sodium Chloride 9mg/ml Injection (NCT05498467)
- 2022-04-05Also stopped (terminated): Fundacion Clinic per a la Recerca Biomédica, Plasma exchange + Standar medical treatmen (NCT04374539)
- 2022-03-10Results posted on the registry: Swedish Orphan Biovitrum, Emapalumab + Anakinra (NCT04324021)
- 2022-03-10Also stopped (terminated): Swedish Orphan Biovitrum, Emapalumab + Anakinra (NCT04324021)
- 2022-03-04Phase 3 first posted: Nationwide Children's Hospital, Anakinra + Placebo (NCT05267821)
- 2022-01-25Also stopped (withdrawn): Weill Medical College of Cornell University, Anakinra + 0.9% Saline (NCT04603742)
- 2021-11-24Also stopped (terminated): Cale Jacobs, PhD, anakinra (150mg) (NCT02930122)
- 2021-10-27Results posted on the registry: Cale Jacobs, PhD, anakinra (150mg) (NCT02930122)
- 2021-06-30Also stopped (terminated): Swedish Orphan Biovitrum, anakinra + Placebo (NCT03265132)
- 2021-06-11Also stopped (withdrawn): Oslo University Hospital, Anakinra 100 mg in 2 ml saline IA (NCT01997138)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision